Sinopharm
1099.HK
#2603
Rank
โ‚น672.91 B
Marketcap
โ‚น215.63
Share price
1.44%
Change (1 day)
4.49%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2025: โ‚น7.910 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.910 Trillion. In 2025 the company made a revenue of โ‚น7.910 Trillion an increase over the revenue in the year 2024 that were of โ‚น7.706 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2025

Annual revenue

Year Revenue Change
2025โ‚น7.910 T2.65%
2024โ‚น7.706 T-5.1%
2023โ‚น8.121 T5.42%
2022โ‚น7.703 T-2.1%
2021โ‚น7.868 T16.85%
2020โ‚น6.733 T14.95%
2019โ‚น5.857 T21.52%
2018โ‚น4.820 T5.93%
2017โ‚น4.550 T27.22%
2016โ‚น3.576 T5.37%
2015โ‚น3.394 T9.14%
2014โ‚น3.110 T17.22%
2013โ‚น2.653 T25.94%
2012โ‚น2.106 T34.61%
2011โ‚น1.565 T55.34%
2010โ‚น1.007 T35.79%
2009โ‚น741.96 B37.56%
2008โ‚น539.38 B31.43%
2007โ‚น410.41 B40.26%
2006โ‚น292.60 B